Biodelivery Sciences International reported $6.36M in Cost of Sales for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Acelrx Pharmaceuticals ACRX:US $ 0.44M 0.6M
Adamas Pharmaceuticals ADMS:US 576K 49K
Agile Therapeutics AGRX:US 2.71M 1.57M
Alimera Sciences ALIM:US $ 1.69M 0.12M
Biocryst Pharmaceuticals BCRX:US $ 0.62M 0.27M
Biodelivery Sciences International BDSI:US $ 6.36M 2.08M
Daiichi Sankyo 4568:JP Y 87407M 2255M
Depomed DEPO:US $ 3.05M 0.87M
Endo International Ordinary Shares ENDP:US $ 297.12M 16.31M
JAZZ PHA JAZZ:US $ 145.22M 26.03M
Johnson & Johnson JNJ:US $ 7250M 317M
Knight Therapeutics Inc GUD:CN C$ 35.57M 1.35M
Lannett LCI:US $ 85M 1.65M
Mannkind MNKD:US $ 9.89M 0.04M
Nektar Therapeutics NKTR:US $ 5.31M 2.36M
Pacira Pharmaceuticals PCRX:US $ 34.65M 0.6M
Pfizer PFE:US $ 9931M 2939M
Redhill Biopharma RDHL:US $ 9.23M 1.36M
Revance Therapeutics RVNC:US $ 5.89M 460K
Teva Pharmaceutical TEVA:IT 1.99B 2M